高参数甲状腺反量基指数是德国人口样本2型糖尿病的预测指标
Martin Laclaustra1,2,3,4, Vanesa Alonso-Ventura1,5, Sabine Schipf6,7
1Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50009 Zaragoza, Spain.
The Journal of clinical endocrinology and metabolism
|February 29, 2024
概括
通过参数甲状腺反量基指数 (PTFQI) 测量甲状腺激素的垂体敏感性降低与患2型糖尿病的风险增加有关. 即使考虑到身体质量指数 (BMI),这种关联仍然存在.
科学领域:
- 内分泌学 在内分泌学.
- 代谢健康 代谢健康
- 流行病学 流行病学
背景情况:
- 2型糖尿病通常与甲状腺功能低下有关.
- 最近的发现表明,对甲状腺激素的垂体敏感性降低与糖尿病,肥胖和代谢综合征有关.
研究的目的:
- 调查甲状腺激素对垂体敏感性和2型糖尿病发病率之间的纵向关联.
- 在德国,利用基于人口的波梅兰健康研究 (SHIP).
主要方法:
- 在基线没有糖尿病或甲状腺药物治疗的2542名参与者的分析,随访了5年.
- 使用基线自由甲状腺素 (fT4) 和甲状腺激素 (TSH) 水平计算参数甲状腺反量基指数 (PTFQI).
- 根据年龄,性别和BMI调整的Poisson回归模型,以评估PTFQI与发生的2型糖尿病的关联.
主要成果:
- 较高的PTFQI四分位数与2型糖尿病发病率的增加有关.
- 在经过年龄和性别调整后,上四分位数的发病率比为1.54-1.97 (P趋势=.004).
- 在进一步对BMI进行调整后,这种关联仍然显著,第四个四分位数的IRR为1.64 (P趋势=0.043).
结论:
- 垂体TSH抑制值升高与发生的2型糖尿病独立相关.
- PTFQI可以作为预测2型糖尿病风险和监测代谢健康的宝贵工具.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Carbohydrate Metabolism
11.1K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.1K
Insulin: Dosing Regimen and Adverse Effects
170
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
170
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282


